Zevra Therapeutics Stock Forecast - Day Typical Price
| ZVRA Stock | 9.51 0.00 0.00% |
Zevra Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Zevra Therapeutics stock prices and determine the direction of Zevra Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Zevra Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Zevra |
| Previous Day Typical Price | Day Typical Price | Trend |
| 9.52 | 9.52 |
| Check Zevra Therapeutics Volatility | Backtest Zevra Therapeutics | Information Ratio |
Zevra Therapeutics Trading Date Momentum
| On November 29 2024 Zevra Therapeutics was traded for 9.51 at the closing time. The top price for the day was 9.66 and the lowest listed price was 9.39 . There was no trading activity during the period 0.0. Lack of trading volume on November 29, 2024 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 0.00% . |
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
| Compare Zevra Therapeutics to competition |
Other Forecasting Options for Zevra Therapeutics
For every potential investor in Zevra, whether a beginner or expert, Zevra Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zevra Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zevra. Basic forecasting techniques help filter out the noise by identifying Zevra Therapeutics' price trends.View Zevra Therapeutics Related Equities
| Risk & Return | Correlation |
Zevra Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Zevra Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Zevra Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Zevra Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Zevra Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zevra Therapeutics shares will generate the highest return on investment. By undertsting and applying Zevra Therapeutics stock market strength indicators, traders can identify Zevra Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 0.028 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 9.53 | |||
| Day Typical Price | 9.52 | |||
| Market Facilitation Index | 0.27 | |||
| Price Action Indicator | (0.01) |
Zevra Therapeutics Risk Indicators
The analysis of Zevra Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zevra Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zevra stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.48 | |||
| Semi Deviation | 3.19 | |||
| Standard Deviation | 3.34 | |||
| Variance | 11.13 | |||
| Downside Variance | 12.9 | |||
| Semi Variance | 10.19 | |||
| Expected Short fall | (2.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zevra Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zevra Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zevra Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zevra Therapeutics Stock:Check out Historical Fundamental Analysis of Zevra Therapeutics to cross-verify your projections. For information on how to trade Zevra Stock refer to our How to Trade Zevra Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zevra Therapeutics. If investors know Zevra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zevra Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.13) | Revenue Per Share 0.575 | Quarterly Revenue Growth 0.276 | Return On Assets (0.33) | Return On Equity (1.31) |
The market value of Zevra Therapeutics is measured differently than its book value, which is the value of Zevra that is recorded on the company's balance sheet. Investors also form their own opinion of Zevra Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Zevra Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zevra Therapeutics' market value can be influenced by many factors that don't directly affect Zevra Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zevra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zevra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zevra Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.